| MOLECULAR PARTNERS ADR |
| USA |
| Gesundheit |
| US60853G1067 / A3CSB5 |
| 6ML0 (Frankfurt) / MOLN (NASDAQ) |
| FRA:6ML0, ETR:6ML0, 6ML0:GR, NASDAQ:MOLN |
| - |
| https://www.molecularpart.. |
|
Molecular Partners AG Sponsored ADR allows investors in the United States to gain exposure to the operations of Molecular Partners AG, a Swiss-based biotechnology company. The primary function of this asset is to facilitate access to the company's st..
>Volltext.. |
| 133.62 Mio. EUR |
| 35.85 Mio. EUR |
| - |
| -55.36 Mio. EUR |
| -64.06 Mio. EUR |
| -1.72 EUR |
| 3.98 Mio. EUR |
| 101.76 Mio. EUR |
| -51.94 Mio. EUR |
| 8.44 |
| -100% |
| -20.5% |
| - |
| - |
| - |
| - |
| MOLECULAR PARTNERS ADR, MOLECULAR PARTNERS |
| 05.04.26 |
|